HRTX icon

Heron Therapeutics
HRTX

Overview Fund Activity

196 hedge funds and large institutions have $3.33B invested in Heron Therapeutics in 2018 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 11 closing their positions.

Holders
196
Holders Change
+44
Holders Change %
+28.95%
% of All Funds
4.49%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.25%
New
57
Increased
66
Reduced
54
Closed
11
Calls
$41.6M
Puts
$107M
Net Calls
-$65M
Net Calls Change
-$68.7M

Top Buyers

1
Fidelity International
1
Fidelity International
Bermuda
$115M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$185M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$176M
4
BlackRock
4
BlackRock
New York
$177M
5
BM
5
Bridger Management
New York
$77.6M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$228M
2
Balyasny Asset Management
2
Balyasny Asset Management
Illinois
$0
3
Franklin Resources
3
Franklin Resources
California
$231M
4
BC
4
Broadfin Capital
New York
$20.2M
5
KCM
5
Kingdon Capital Management
New York
$31.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
AC
201
Athanor Capital
New York
– -$966K -35,000 Closed
DZ Bank
202
DZ Bank
Germany
– -$361K -13,062 Closed
Marshall Wace
203
Marshall Wace
United Kingdom
– -$334K -12,100 Closed
FANJ
204
Financial Architects (New Jersey)
New Jersey
– -$8K -300 Closed
APP
205
Avantax Planning Partners
Iowa
– -$4K -160 Closed
WAS
206
Winch Advisory Services
Wisconsin
– -$3K -100 Closed
5 6 7 8
9